Tokyo, Dec. 22 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060135) titled 'Effect of early intervention using continuous glucose monitoring (CGM; FreeStyle Libre 2) for prevention of hyperglycemic adverse events in patients receiving capivasertib' on Dec. 22.
Study Type:
Interventional
Study Design:
Basic Design - Single arm
Randomization - Non-randomized
Blinding - Open -no one is blinded
Control - Uncontrolled
Primary Sponsor:
Institute - Kyoto Prefectural University of Medicine
Condition:
Condition - Hormone receptor positive, HER2 negative unresectable or recurrent breast cancer with PIK3CA, AKT1, or PTEN gene mutations that has progressed after endocrine therapy
Classification by m...